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Abstract
Aims
This study aims to identify critically important features of digital type two diabetes mellitus
(T2DM) prevention interventions.
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Methods
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A stakeholder mapping exercise was undertaken to identify key end-user and professional
stakeholders, followed by a three-round Delphi procedure to generate and evaluate evidence statements related to the critical elements of digital T2DM prevention interventions in
terms of product (intervention), price (funding models/financial cost), place (distribution/
delivery channels), and promotion (target audiences).

Published: August 5, 2021
Copyright: © 2021 Ryan et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data cannot be
shared publicly due to the conditions of the ethics
approval and potentially identifiable nature of the
qualitative data. Interested researchers may apply
for access to the data by contacting The
Commonwealth Scientific and Industrial Research
Organisation Human Research Ethics Committee
(chmhrec@csiro.au).
Funding: This work was funded by an internal
seed-funding grant provided by the
Commonwealth Scientific and Industrial Research

Results
End-user (n = 38) and professional (n = 38) stakeholders including patients, dietitians, credentialed diabetes educators, nurses, medical doctors, research scientists, and exercise
physiologists participated in the Delphi study. Fifty-two critical intervention characteristics
were identified. Future interventions should address diet, physical activity, mental health
(e.g. stress, diabetes-related distress), and functional health literacy, while advancing
behaviour change support. Programs should be delivered digitally or used multiple delivery
modes, target a range of population subgroups including children, and be based on collaborative efforts between national and local and government and non-government funded
organisations.
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Stakeholder perspectives in digital diabetes

Conclusions
Our findings highlight strong support for digital health to address T2DM in Australia and
identify future directions for T2DM prevention interventions. The study also demonstrates
the feasibility and value of stakeholder-led intervention development processes.

Background
Growing prevalence of lifestyle-related chronic diseases including Type 2 Diabetes Mellitus
(T2DM) has created an enormous need for innovative and effective ways to support people to
proactively manage their health [1, 2]. T2DM directly affects about 1 million Australian adults,
while a further 2 million are estimated to have pre-diabetes, indicating that they are at significant risk of developing T2DM in the near future [3]. While T2DM can be prevented or
reversed by addressing its lifestyle-based antecedents, primarily, overweight or obesity, poor
diet, and physical inactivity [4], translating this advice into actionable and effective behaviour
change support is an ongoing public health challenge. Health-related behaviours are difficult
to change and furthermore, sustaining health behaviour change is even harder, with behavioural changes often reverting to baseline levels over time [5].
Health interventions that harness digital delivery and technologies, such as smartphone
apps and wearable trackers, are increasingly used to deliver health behaviour change support
for people at risk or with T2DM and other chronic diseases [6]. Such digital approaches offer
significant benefits. For example, digital interventions are able to integrate principles of ‘persuasive design’ such as personalisation, gamification, and social influence; as well as behaviour
change techniques such as self-monitoring to encourage users to take up behavioural change
[7–9]. They also piggyback on existing habitual smartphone and internet use to deliver intense
behaviour change support programs. Furthermore, digital health interventions are highly scalable, able to be disseminated to large audiences at minimal cost-per-user, which is of critical
importance in context of the growing need for such tools [10]. Taken together, digital health
offers enormous potential as a cost-effective means to expand access to care among populations with access to digital technologies which may help to meet some of the growing need for
chronic disease support and prevention [6].
Research and development related to digital health solutions for chronic disease is rapidly
expanding. Interventions draw upon a wide range of health information technologies, including smartphone apps, intelligent algorithms (e.g. artificial intelligence or AI), continuous glucose monitoring, social media, and the internet more broadly [11]. They may be delivered via
websites, smartphones, or text messages, and often seek to supplement clinical care options
(e.g. telehealth) or change behaviours through self-monitoring of diet, activity, or glucose levels or through personalised health advice generated using AI [11]. To date, research has generated promising evidence for the efficacy of digital health interventions in controlled trial
settings [12]. For example, one study by Spring and colleagues found an m-health intervention
targeting multiple behavioural health risk factors was effective in improving activity and diet
behaviours to recommended levels, with effects sustained to a 9-month follow up [13]. Digital
translations based on the landmark Diabetes Prevention Program intervention [4] have also
been shown to be effective in clinical trial conditions, with results sustained for several years in
some cases [14, 15].
On the other hand, less is understood about how to best translate digital health solutions
into real-world conditions and in ways that engage and meet the needs of diverse stakeholders
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[6]. Translating and implementing health evidence involves the design of programs that are
highly acceptable, effective, and relevant to key stakeholders, including end-user and clinical
stakeholders [16]. Achieving this is inhibited by a key limitation of digital health, which is that
it is more easily abandoned by the user [17, 18]. Research by Vaghefi and Tulu identified a
number of factors that drive abandonment of m-health programs, which included users’ perceptions of design elements (e.g. interface, navigation, and notifications), the depth of knowledge or content available in the app, and clarity of system rules [19]. Furthermore, changes in
the individuals’ motivation and persistence also played an important role, with these factors
tending to wane over time, leading to abandonment or reduced engagement with the program
[19]. From the perspective of clinicians, factors affecting engagement with mobile health (mhealth) tools relate more to the usability of such tools including interoperability with current
work systems, as well as the influence of peers and whether tools are championed by others
and the organisations themselves [20]. The range and complexity of factors affecting engagement with m-health highlight the need for stakeholder engagement in their design and evaluation. These challenges represent the next frontier for digital health, as we move towards the
implementation of digital health for chronic disease into policy and practice [21].
Since effective implementation of health evidence is reliant on active support from the target audience, the broad inclusion of relevant stakeholders in multiple stages of research development and translation (i.e. participatory research) can increase the implementation potential
of health interventions [22]. As a result, participatory research practices are strongly advocated
by leading health authorities as a best-practice approach to evidence translation and implementation [23, 24]. Although full integration of participatory practices into health research is
still limited, some studies have highlighted a range of benefits to service provision (e.g. shifts in
organisational change, achieving collaboration and mutual learning, capacity building) [20]
and translation outcomes [25, 26]. These include more novel and innovative idea generation
and creativity and more support and enthusiasm for innovation [27]. Risks associated with
failing to engage stakeholders have also been documented, which is considered to be a contributing factor towards high rates of research ‘waste’, including an estimated 50% of clinical trial
results being unpublished and duplication of studies including the perpetuation of avoidable
design flaws [28]. Participatory research practices can help to address challenges associated
with engaging and retaining users and are therefore critical to progressing the impact of digital
health into practice and policy [22].
In this participatory study, we worked with key stakeholders to identify key characteristics
and needs associated with digital T2DM prevention and self-management solutions in the
Australian context. We describe the process of identifying key stakeholders and engaging
them in the initial steps of co-generating intervention ideas through a Delphi consensus study.
Because T2DM is a serious medical condition that requires clinical support, we placed strong
emphasis on the views of both end-user stakeholders (i.e. patients or those at risk of or diagnosed with T2DM) and professional stakeholders (i.e. health practitioners, T2DM managers,
scientists and researchers, etc). This study represents the first step in a broader program of
research that seeks to demonstrate how co-design can be used to develop interventions and
translate them into community and practice. More specifically, the study aims to:
Stage 1 Stakeholder Mapping. Examine who are the key stakeholders for T2DM prevention
and management in Australia and how can they be identified and recruited.
Stage 2 Delphi Study. Generate innovative ideas and identify key characteristics of future digital health interventions designed to help people with T2DM or pre-diabetes to adopt and
sustain health behaviour change.
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Methods
This study was approved by the Commonwealth Scientific and Industrial Research Organisation Human Research Ethics Committee (Application #CSIRO_2019_102_LR) and conducted
and reported in accordance with Guidance on Conducting and Reporting Delphi Studies [29].
All participants provided informed consent to take part in the study via the online survey. The
study took place between September 2019 and June 2020.

Stage 1. Stakeholder mapping and engagement
We followed the stakeholder mapping process described by Schiller et al. [30] in order to identify and recruit a panel of relevant stakeholders. First, two members of the authorship team
(J.R. and B.W.) created a list of disciplines relevant to T2DM prevention by collating the academic affiliations of authors and MESH headings of studies included in key relevant systematic
reviews [31–34]. Once relevant academic disciplines and topics had been identified, these were
extrapolated into professional, clinical, and policy-related roles, following Concannon et al.’s
health stakeholder taxonomy structure (see Fig 1); Patients and the Public, Providers, Purchasers, Payers, Policy Makers, Product Makers, and Principal Investigators [35].
Relative importance of each stakeholder was then evaluated based on the perceived likelihood of interest (i.e. how determined an individual in this role is to address T2DM) and perceived strength of influence [30]. Each study author separately rated each stakeholder-type
based on these criteria (interested/influential: yes/no) and then came together to discuss which
stakeholder-types were of greatest priority.
Stakeholder engagement. Next, we sought to recruit stakeholders as Delphi study participants. Previous Delphi studies have reported a median of 17 (IQR: 11–31) participants, typically representing 2–3 stakeholder groups [36]. Smaller panels are vulnerable to significant

Fig 1. Stakeholder map including examples of key individual or organisation stakeholder roles.
https://doi.org/10.1371/journal.pone.0255625.g001

PLOS ONE | https://doi.org/10.1371/journal.pone.0255625 August 5, 2021

4 / 16

PLOS ONE

Stakeholder perspectives in digital diabetes

influence from any one panel member and it is important to consider the weight of each
respondents’ influence against the criteria for consensus (e.g. 80% must agree, in a panel of
ten, one person = 10% of consensus) [37]. Anticipating dropout rates of approximately 20%
over three rounds [38], we therefore aimed to recruit 76 stakeholders to ensure we would
maintain the minimum sample size required for the study. We targeted two stakeholder categories, end-users (e.g. people at risk of T2DM or diagnosed with pre-diabetes or T2DM) and
professional stakeholders (e.g. health practitioners, managers, scientists, etc with at least two
years’ experience working in a diabetes-related field). Potential stakeholders were contacted
via personalised emails that contained an invitation to take part and a weblink to an online
registration survey. All stakeholders were offered an honorarium of $50 AUD upon completion of all three rounds of data collection.
To develop the list of professional stakeholder contacts, a template was prepared outlining
all key stakeholder categories and types/roles. Authors were invited to populate the template
based on their experience, which was supplemented by online searches as well as searches of
the author list of relevant systematic reviews to create a broad list of stakeholders. End-user
stakeholders were recruited from a database of previous research participants who had indicated that they would be interested in participating in future studies. To be eligible, end-user
stakeholders had to self-identify as having T2DM or pre-diabetes. On the other hand, professional stakeholders were required to have at least two years’ experience working in a diabetesrelated role but were not restricted based on any health-related criteria. All eligible participants
were at least 18 years old.
Stakeholders. The stakeholder mapping procedure identified 171 potential participants
(121 professional and 50 end-user stakeholders) who were eligible to participate in the Delphi
study. A weblink to an initial Expression of Interest (EOI) to participate was emailed to all 171
stakeholders. In total, 112 stakeholders clicked on the EOI and of these, 76 completed the
study enrolment procedure and Round One survey instrument (68% acceptance rate). Of
these, 61 stakeholders participated in the three Delphi rounds (80% completion rate).

Stage 3: Stakeholder consultation via Delphi study
Stakeholders were consulted on their perceptions of the ideal characteristics of future digital
health programs via a three-round classical Delphi study (Fig 3). Delphi studies are a systematic approach to achieving consensus among key stakeholders, to gain insight or clarity in an
area of challenge or complexity. The Delphi study was administered via online survey using
Survey Gizmo software and each round had a pre-determined and specific purpose (described
subsequently). Prior to commencing each survey, stakeholders were instructed to read context-setting information explaining the purpose of the study and to provide definition of key
terminology such as pre-diabetes.
Delphi Round One. The purpose of the Delphi Round One was to generate evidence
statements about preferred characteristics of digital T2DM interventions. Via an online survey,
participants answered open-ended questions related to the marketing mix (i.e. product, price,
place, and promotion, [39]), for example, ‘how should (a digital health T2DM program) be
delivered?’. No pre-specified ideas were provided to participants. These were followed by nine
questions to capture the respondents’ age, sex, education level; employment status, occupation,
and income; diabetes status, and contact information.
Round 1 data was analysed using inductive thematic analysis to group responses in themes
[40]. First the data were exported into Microsoft Excel. Following data familiarisation, one
author analysed the data by placing each response into broad themes. These categorisations
were validated by another author to establish inter-rater reliability. Finally, the remainder of
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the dataset was categorised, and the evidence statements were then presented to the broader
research team for feedback and refinement.
Round Two. In Round Two stakeholders rated each of the themes or evidence statements
generated in Round One using the 9-point Grading of Recommendations, Assessment, Development and Evaluations (GRADE) scale with three categories: not important (1–3), important
but not critical (4–6), and critically important (7–9) [41]. Stakeholders were also able to suggest new items or comment on existing items in Round Two.
Definition of consensus. Round Two data were analysed descriptively to determine which
evidence statements reached consensus. Evidence statements that reached consensus were
automatically passed through to the final round while statements that did not reach consensus
were passed through to Round Three for further evaluation. Statements were deemed to have
reached consensus when a certain level of group agreement was reached, more specifically, at
least 70% of respondents rated an item as ‘critically important’ and no more than 15% of
respondents rated that same item as ‘not important’ [42]. Conversely, in the instance that at
least 70% of respondents rated an item as ‘not important’ and no more than 15% rated the
item as ‘critically important’, items could be deemed unimportant by consensus. Responses
and the level of agreement for each statement were analysed separately for the two stakeholder
groups.
Round Three. The aim of Round Three was to provide an opportunity for participants to
re-rate statements that did not reach consensus with the objective to increase group consensus
about its importance (while recognising that only a small increase in consensus is likely) and
to further clarify respondents’ appraisal and importance of each statement [43]. Stakeholders
were presented with the statements that had not reached consensus in Round Two as well as
additional information about how their participant group (end-user or professional stakeholders) rated each statement. More specifically, the median and range scores and a frequency histogram depicting the spread of scores were provided. An example presented in Fig 2 displays

Fig 2. Example of group-level feedback on ratings of one evidence statement capturing the importance of supermarket
tours as an intervention component.
https://doi.org/10.1371/journal.pone.0255625.g002
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professionals’ ratings of the importance of including supermarket tours in digital T2DM programs (a ‘product’ variable).
Flow of evidence statements throughout study. Round One identified 66 evidence statements (end-user stakeholders) and 63 statements (professional stakeholders). The flow of evidence statements through Rounds One to Three is depicted in Fig 3. By Round Three, 52
(end-user stakeholders) and 49 (professional stakeholders) statements met group consensus of
critical importance while no statements in either group met the criteria for consensus of nonimportance.

Results
Participants
A total of 76 stakeholders enrolled in the study. Of these, 38 were end-user stakeholders, 32%
of whom were female and 84% of whom were at least 50 years old (see Table 1). Twenty-four
percent of the end-user stakeholder group had pre-diabetes while 63% had T2DM and 13%
were not sure whether they currently had T2DM or pre-diabetes. In the professional stakeholder group, 76% were female and 47% were at least 50 years old. Occupations of the stakeholders in the scientific/clinical stakeholders group included dietitians (n = 9, 23.7%)
managers in relevant organisations (e.g. CEO; n = 6, 15.8%), credentialed diabetes educators
(n = 4, 10.5%), data analysts (3, 7.9%), nurses (n = 4, 10.5%), medical doctors/physicians
(n = 4, 10.5%), research scientists (n = 4, 10.5%), social workers (n = 2, 5.3%), an exercise physiologist (n = 1, 2.6%), and a pharmacist (n = 1, 2.6%).

Product
The product variable considers what features digital T2DM health interventions should
include. Features that promote positive change in the areas of physical activity, diet, mental
health (e.g. stress, diabetes-related distress), health literacy, access to health care services, and
behaviour change success reached consensus agreement of critical importance in both participant groups (see Table 2). Several additional statements reached consensus agreement of
importance in only one of the participant groups. By consensus, end-user stakeholders
reported meal plans as critically important to achieving diet change and reported additional
funding to cover the cost of medical treatment of critical importance while scientific/clinical
stakeholders did not.

Promotion (target audience)
Promotion considers the target audience of the product. End-user and professional stakeholders agreed that specific programs should be developed for the different target audiences, in
particular.
• people with pre-diabetes or at high risk,
• people with T2DM,
• adults in general,
• families of people with diabetes, and
• people who live in regional, rural, or remote areas specifically.
Early intervention/health promotion for both children and adults were also identified as
critically important by both participant groups.
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Fig 3. Participant and data item flowchart.
https://doi.org/10.1371/journal.pone.0255625.g003

Place
Place considers where and how the product should be delivered. All groups agreed that programs should be delivered via digital platforms (e.g. website, mobile phone application) and/or
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Table 1. Participant characteristics.
End-user stakeholders (N = 38) Professional stakeholders (N = 38)
Gender (n, %n female)

12 (31.6%)

29 (76.3%)

20–29

-

4 (10.5%)

30–39

3 (7.9%)

9 (23.7%)

40–49

3 (7.9%)

7 (18.4%)

50–59

17 (44.7%)

7 (18.4%)

60–69

15 (39.5%)

6 (15.8%)

Missing

-

5 (13.2%)

Year 11 or below

6 (15.8%)

-

Year 12 or equivalent

4 (10.5%)

-

Vocational training

10 (26.3%)

1 (2.6%)

University degree

12 (31.6%)

9 (23.7%)

Postgraduate degree

6 (15.8%)

26 (68.4%)

Age (n, %n)

Highest level of education attained (n, %n)

Missing

2 (5.2%)

Self-reported T2DM status
Current T2DM diagnosis (n, %n yes)

24 (63.2%)

0

Current pre-diabetes diagnosis (n, %n
yes)

9 (23.7%)

1 (3.8%)

5 (13.1%)

1 (3.8%)

Unsure of current diagnosis

https://doi.org/10.1371/journal.pone.0255625.t001

via a mixture of delivery approaches, depending on context. In addition, professional, but not
end-user stakeholders, considered it critically important that interventions have face-to-face
components. Conversely, end-user stakeholders, but not professional stakeholders, considered
it critically important that interventions are delivered via school-based programs.

Price
Stakeholders were asked who should fund the provision of T2DM prevention programs. Both
groups agreed that such programs should be funded by a combination of stakeholders, reflecting demand for co-funded arrangements that include input from both the Federal and State
governments and the contribution of in-kind provision of evidence (e.g. by scientific organisations and universities) or program delivery (e.g. non-governmental organisations like Diabetes
Australia). Furthermore, the end-user but not professional stakeholder group considered that
programs should be funded by a range of other entities including not-for-profit organisations,
universities, and stakeholders; while scientific/clinical stakeholders thought that local government and councils should fund such programs.

Discussion
This study used stakeholder mapping combined with a three-round Delphi study to identify
critically important characteristics of digital T2DM prevention interventions. The Delphi consultation process identified at least 52 characteristics considered critically important by consensus within the two groups of stakeholders. Key findings include firstly, that digital tools are
needed to help the target population to improve their physical activity levels, diet, mental
health, and functional health literacy, which includes their ability to manage their health and
knowledge of health care systems. Secondly, programs are needed that incorporate behaviour
change techniques that seek to increase self-efficacy for change, as well as measures to address
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Table 2. Participant-generated ideas for health promotion program.
Intervention domain

Evidence statement

Rated as critically important by:
End user
stakeholders

Physical activity

Diet

Psychological health

Health literacy

Access to health care
services

Behaviour change

Professional
stakeholders

• Education about the link between physical activity and T2DM

✓

✓

• Practical resources to support physical activity (e.g. subsidised gym memberships, exercise
programs.)

✓

✓

• Exposure to relevant allied health care scientific/clinical stakeholders (e.g. exercise
physiologists).

✓

✓

• Education about the link between diet and T2D

✓

✓

• Healthy recipes

✓

✓

• Meal plans

✓

✗

• Access to fresh and healthy foods (e.g. affordable fruit and vegetables)

✓

✓

• Education about the link between T2D and mental health

✓

✓

• Stress management techniques

✓

✓

• Positive mental health promotion

✓

✓

• Education about the links between health and lifestyle factors (e.g. smoking, physical
activity, diet, alcohol).

✓

✓

• Education about the link between T2D and cardio-vascular disease.

✓

✓

• Demographic health risk factors (e.g. sex, age)

✗

✓

• Funding/subsidies to cover the cost of medication or medical treatment

✓

✗

• Education about how to access funds to pay for medical costs (e.g. Medicare, private health
insurance)

✓

✓

• Contact/exposure to a variety of health care scientific/clinical stakeholders

✓

✓

• Success stories to motivate and empower users

✓

✓

• Reviews of current lifestyles to help identify areas for improvement.

✓

✓

• Access to biomarker self-monitoring technology (e.g. continuous glucose monitoring).

✓

✓

• Behavioural self-monitoring (e.g. exercise and diet diaries).

✓

✓

• Online social support networks

✓

✓

✗

✓

• Increase neighbourhood walk-ability (e.g. number of safe pathways that connect to
important places like bus stops, shops)

✓

✓

• Increase available green space in neighbourhood (e.g. parks, trees, gardens)

✗

✓

Environmental strategies • Changes to policy (e.g. sugar tax, free access to lifestyle programs)

https://doi.org/10.1371/journal.pone.0255625.t002

environmental limitations on health behaviours (e.g. lack of walking paths). Thirdly, it is critically important that programs target people who are at-risk of T2DM before they develop
T2DM (primary prevention). In addition, vulnerable groups such as those who live in rural
and regional remote areas require tailored programs that differ from those targeting the general population. Finally, programs are needed that are entirely or partially delivered via digital
means.

Comparison with previous literature
Similar to previous research [44] this study uncovered some novel findings while also confirming some commonly-accepted arguments within chronic disease prevention. Our finding that
future T2DM prevention programs should target physical activity, diet, psychological health,
health literacy, access to healthcare services and behavioural change was consistent with a similar study conducted in the UK. In that research, participants living with T2DM sought assistance with diet and physical activity, support for self-management strategies, assistance in
understanding in-depth or complex information in an intervention [44].
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A strong theme that ran through participant responses was the need for tools that help to
boost health literacy in patients with pre-diabetes. Previous research has similarly highlighted
uncertainty associated with the diagnosis of pre-diabetes and what was going to happen to
patients as a major source of stress for people with pre-diabetes [45]. Although health literacy
is a well-known determinant of health and predictor of chronic diseases, conventional operationalisations of health literacy within diabetes interventions have had a strong focus on health
education about disease self-management and lifestyle factors [46] as well as health literacy
and numeracy [47], without addressing the broader contextual, practical, and functional
aspects of health literacy identified in this study, which are also part of more contemporary
health literacy frameworks [48]. Functional health literacy, as described by Osborne and colleagues, contains nine conceptually distinct areas of health literacy, such as ‘having sufficient
information to manage my health’, ’feeling understood and supported by healthcare providers’, and ’ability to actively engage with healthcare providers’ [48]. Educational interventions
are essential to patients’ ability to seek further support, understand the health care system, and
take steps to change their lifestyles, which have significant implications for health outcomes.
In Australia, pre-diabetes is often approached in a watch-and-wait approach with limited
health behaviour change support offered, which is contributing to high rates of progression to
T2DM. A limited set of national and state-based T2DM education tools are available, many of
which are based upon evidence-based interventions such as the DESMOND model [46]. The
National Diabetes Services Scheme (NDSS), for example, offers a ‘Type 2 Diabetes and Me’
free online course (https://www.ndss.com.au/services/support-programs/), as well as support
programs and information sessions. However, few of these programs are specific to pre-diabetes and furthermore it is not clear or visible to the end-user stakeholder whether current offerings were developed on a foundation of meaningful community engagement, which can limit
community uptake of such programs [49]. Community-driven initiatives that support the
unique health literacy support needs of people with pre-diabetes and are visibly stakeholderdriven remain a promising area for research to improve the translational impact of T2DM prevention education initiatives.
In terms of program delivery, our results indicate that while professional stakeholders
group considered face-to-face interactions (either group-based or one on one) as critically
important, end-user stakeholders did not. This is interesting in comparison with previous
research where adults with T2DM in Europe expressed a desire for interactive, face-to-face
treatment and lifestyle support intervention [50]. It is possible that the COVID-19 pandemic
has accelerated clinical implementation and subsequent adoption and acceptance of e-health
and telephone clinical services, which may have also contributed to high demand for digital
services detected in our study. In the future, digital and face-to-face clinical services need to
co-exist in blended models as one is not a complete solution.

Stakeholder engagement: Lessons learned
Study acceptance and completion rates were high, both from a practical perspective (80% of
participants completed the study to the end) and relative to previous Delphi studies [36, 51].
As this process was delivered via an entirely hands-off and online protocol the study demonstrates an efficient and potentially cost-effective method of meaningfully engaging with stakeholders in the co-design of digital health for chronic disease interventions [36, 51]. Similar to
previous research [51], anecdotally it was noted that the use of personalised contact including
phone calls to each participant likely contributed to the high-quality engagement achieved. A
number of pragmatic benefits to participating in Delphi studies were also mentioned in participant communication. An honorarium that approached fair compensation for stakeholders’
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time was appreciated, while it was reminded that participation in this type of research and
stakeholder engagement activities can count towards continuing professional development
points for certain roles. In future, these benefits might be communicated clearly in recruitment
materials to facilitate participant recruitment and retention.

Directions for future research
This study provides some direction on the design of digital health prevention programs for
T2DM. Currently, few evidence-based, disease-specific programs are widely available in Australia to help people to adopt healthier lifestyles. Further research is needed to identify how evidence-based solutions can be effectively translated into the community and clinical practice.
User-centred methodologies including Delphi studies and other co-design strategies will be
key to overcoming the complex challenge of designing interventions that are appealing and
engaging for end users.
Further research is needed to identify needs and preferences among under-served, minority, elderly, and other vulnerable groups. While our findings may be generalisable to the majority of the Australian population, they have also highlighted the need for unique solutions
tailored towards people living in remote and rural areas, people from culturally and linguistically diverse backgrounds, and other under-served, minority, and vulnerable groups. In addition, as digital health continues to spread through our health systems, further work is needed
to understand and address the growing ‘digital divide’ including who and in what ways people
may be disadvantaged by the digital revolution. Digital health is evolving rapidly, with a stream
of new technologies entering the market each year, making it difficult to keep abreast of the latest innovation. To maximise returns on investment, attention should focus on technologies
that are succeeding in other fields, such as education or gaming, to identify overlaps for health.
More research investment is needed in this area.

Study strengths and limitations
This study applied strict adherence to the classical 3-round Delphi Study approach. This
approach was effectively implemented and able to demonstrate the value of acquiring consensus in complex health issues, namely T2DM. Finally, this study sought the involvement of both
professional stakeholders actively working in the field of T2DM, and potential end-user stakeholders of a T2DM prevention programme, and therefore gained insights from two distinct
but equally relevant stakeholder groups. This extends previous work assessing a singular stakeholder group [44] and that enabled the analysis of consensus achieved in either groups, or as a
total sample, and assisted in identifying similarities and differences what each group values in
an intervention.
In addition to study strengths it is also important to consider the limitations. Study findings
are based on a sample of stakeholders and may not necessarily be representative of all end-user
or professional stakeholders’ views. While thorough consideration was given to the selection of
stakeholder groups, it is possible that some key professions were underrepresented in the professional stakeholder group. For example, it was noted during data analysis that educators
including teachers and those involved in establishing the school curriculum are relevant stakeholders, however, these were not considered in our stakeholder map and only emerged from
the results. In terms of the socio-demographic profiles of stakeholders there is also a gender
bias with end-user and professional stakeholder groups skewed towards males and females,
respectively. Finally, the specific T2DM outcomes of this study are specific to the Australian
health landscape as the content is specific to the Australian population and perhaps other

PLOS ONE | https://doi.org/10.1371/journal.pone.0255625 August 5, 2021

12 / 16

PLOS ONE

Stakeholder perspectives in digital diabetes

countries with freely available universal healthcare, though the methodological contributions
may have more general application.

Conclusions
This 3-round classical Delphi study confirm the need for further evidence- and theory- based
tools that support improvements in physical activity, diet, and mental health as core targets, as
well as an expanded definition of functional health literacy that encompasses the skills and
knowledge needed to access health care services. The broader field of public health would benefit from further use of stakeholder engagement through rigorous research designs, such as
Delphi studies, to analyse complex and multi-faceted areas of health management and disease
prevention.
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